{
  "case_id": "case_0008",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 48.93,
    "sex": "Female",
    "genderIdentity": "Cisgender Male",
    "ancestry": "Sub-Saharan African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesion involving:\n- length-dependent peripheral polyneuropathy.",
      "structured_data": {
        "gt_lesions_english": [
          "length-dependent peripheral polyneuropathy"
        ],
        "ft_lesions_parsed": [
          {
            "location": "length-dependent peripheral polyneuropathy",
            "side": "bilateral",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "length-dependent peripheral polyneuropathy"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 1,
        "correctly_identified_count": 1,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Peripheral neuropathy.\n\nAgree to also consider:\n- Paraproteinemic Neuropathy, Vasculitic Neuropathy, CIDP, Vitamin B12 Deficiency, Diabetes-related Neuropathy, Alcohol-related Neuropathy and Hypothyroid Neuropathy.\n\nOther possible differentials:\n- Uraemic Neuropathy, Guillain-Barre Syndrome and HIV Neuropathy.\n\nOther considerations not mentioned:\n- The presenting complaint may be distinct from the neurological signs and due to something like Congestive heart failure, Chronic venous insufficiency or Kidney disease, if the signs are chronic.\n\nLess plausible as unifying explanation for the full clinical presentation:\n- Hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease) (atypical for length-dependent peripheral polyneuropathy involvement)\n- Paraneoplastic sensorimotor peripheral neuropathy (atypical for length-dependent peripheral polyneuropathy involvement)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Chronic length-dependent sensorimotor peripheral polyneuropathy of metabolic or toxic aetiology",
          "Diabetic sensorimotor polyneuropathy",
          "Alcohol-related peripheral neuropathy",
          "Vitamin B12 deficiency-related peripheral neuropathy",
          "Hypothyroid peripheral neuropathy",
          "Peripheral neuropathy associated with monoclonal gammopathy (e.g. MGUS or multiple myeloma)",
          "Chronic inflammatory demyelinating polyradiculoneuropathy",
          "Hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease)",
          "Paraneoplastic sensorimotor peripheral neuropathy",
          "Vasculitic peripheral neuropathy"
        ],
        "gt_diagnoses_with_source": {
          "Peripheral neuropathy": "evaluation",
          "Congestive heart failure": "incidental_cause",
          "Kidney disease": "incidental_cause",
          "Chronic venous insufficiency": "incidental_cause"
        },
        "correctly_mentioned_original_gt": [
          "Peripheral neuropathy"
        ],
        "missing_original_gt": [
          "Congestive heart failure",
          "Kidney disease",
          "Chronic venous insufficiency"
        ],
        "matched_lesion_dx_keys": [
          "Paraproteinemic_Neuropathy",
          "Vasculitic_Neuropathy",
          "CIDP",
          "Vitamin_B12_Deficiency",
          "Diabetic_Neuropathy",
          "Alcoholic_Neuropathy",
          "Hypothyroidism_Neuropathy"
        ],
        "missing_lesion_dx_keys": [
          "Uraemic_Neuropathy",
          "Guillain_Barre_Syndrome",
          "HIV_Neuropathy"
        ],
        "missing_common_names": [
          "Uraemic Neuropathy",
          "Guillain-Barre Syndrome",
          "HIV Neuropathy"
        ],
        "missing_low_prob_names": [],
        "additional_diagnoses": [
          "Hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease)",
          "Paraneoplastic sensorimotor peripheral neuropathy"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Peripheral neuropathy",
        "gt_total_count": 4,
        "gt_matched_count": 1,
        "gt_missed_count": 3,
        "gt_coverage_percentage": 0.25,
        "additional_less_plausible_count": 2,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 3,
        "lesion_ddx_total_count": 10,
        "lesion_ddx_matched_count": 7,
        "lesion_ddx_missed_common_count": 3,
        "lesion_ddx_missed_low_prob_count": 0,
        "lesion_ddx_coverage_percentage": 0.7
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested Nerve Conduction Studies and EMG - would potentially inform a diagnosis/details of peripheral neuropathy.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: TFT, ESR, ANCA, LFT, folate, HIV, Nerve conduction studies and EMG, vitamin B12, CRP, FBC, Glucose / HbA1c, protein electrophoresis, U&E.\n- Could also consider testing: methylmalonic acid, Spirometry / FVC, CSF (Analysis (Protein/Cell Count)).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "nerve conduction studies and emg",
            "region": "peripheral_polyneuropathy_length_dependent.bilateral",
            "condition": "Peripheral neuropathy"
          }
        ],
        "ft_proposed_investigations": [
          "Full blood count",
          "Urea and electrolytes",
          "Serum creatinine and estimated glomerular filtration rate",
          "Liver function tests",
          "Serum albumin",
          "HbA1c",
          "Fasting plasma glucose",
          "Thyroid function tests",
          "Serum vitamin B12",
          "Serum folate",
          "Serum protein electrophoresis with immunofixation",
          "Serum immunoglobulin levels",
          "Erythrocyte sedimentation rate",
          "C-reactive protein",
          "HIV serology",
          "Hepatitis B and C serology",
          "Antinuclear antibody",
          "Antineutrophil cytoplasmic antibody",
          "Urinalysis for protein",
          "Urine albumin-creatinine ratio",
          "Nerve conduction studies and electromyography",
          "Ultrasound Doppler of lower limb veins",
          "Echocardiogram",
          "Genetic testing for hereditary motor and sensory neuropathy if clinical or family history suggests"
        ],
        "all_identified_ft_keys": [
          "Hepatitis_Screen",
          "TFT",
          "ESR",
          "Serum_Immunoglobulins",
          "ANA",
          "LFT",
          "Folate",
          "ANCA",
          "HIV_Test",
          "Genetic_Neuropathy_Panel",
          "NCS_EMG",
          "Vitamin_B12",
          "CRP",
          "FBC",
          "Glucose_HbA1c",
          "Urinalysis",
          "Serum_Protein_Electrophoresis",
          "U_and_E"
        ],
        "found_tests_primary": [
          {
            "type": "nerve conduction studies and emg",
            "region": "peripheral_polyneuropathy_length_dependent.bilateral",
            "condition": "Peripheral neuropathy"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "TFT",
          "ESR",
          "ANCA",
          "LFT",
          "Folate",
          "Methylmalonic_Acid",
          "HIV_Test",
          "NCS_EMG",
          "Vitamin_B12",
          "CRP",
          "FBC",
          "CSF_General",
          "Glucose_HbA1c",
          "Spirometry",
          "Serum_Protein_Electrophoresis",
          "U_and_E"
        ],
        "found_inv_keys_ddx": [
          "TFT",
          "ESR",
          "ANCA",
          "LFT",
          "Folate",
          "HIV_Test",
          "NCS_EMG",
          "Vitamin_B12",
          "CRP",
          "FBC",
          "Glucose_HbA1c",
          "Serum_Protein_Electrophoresis",
          "U_and_E"
        ],
        "missing_inv_keys_ddx": [
          "Methylmalonic_Acid",
          "CSF_General",
          "Spirometry"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 1,
        "primary_tests_found_count": 1,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 16,
        "ddx_tests_found_count": 13,
        "ddx_tests_coverage_percentage": 0.8125
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to suggest treatment at this time.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not necessarily a symptom of MS so indication for steroids is unclear.\n\nDMTs: Inappropriate omission. The plan failed to consider this possible treatment option.\n  \nAdditional factors not mentioned:\n\n- Need confirmation of MS diagnosis.\n\n- Need a pregnancy test result.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Lifestyle modifications (weight loss, regular aerobic exercise, smoking cessation if relevant, and limitation of alcohol intake)",
            "timing": "Start Now",
            "reasons": [
              "Safe and beneficial regardless of final aetiology",
              "Obesity and possible metabolic syndrome increase risk of metabolic neuropathy and ankle oedema",
              "Improves long-term cardiovascular, renal, and neurologic outcomes"
            ]
          },
          {
            "treatment": "Foot care education and podiatry referral",
            "timing": "Start Now",
            "reasons": [
              "Distal sensory loss increases risk of unnoticed trauma and ulceration",
              "Early education on daily foot inspection and appropriate footwear reduces complications",
              "Can be implemented before full aetiological workup is completed"
            ]
          },
          {
            "treatment": "Physiotherapy and balance training",
            "timing": "Start Now",
            "reasons": [
              "Mild distal weakness and sensory loss increase fall risk",
              "Strengthening and proprioceptive training can improve functional status",
              "Non-invasive and low-risk intervention"
            ]
          },
          {
            "treatment": "Compression stockings and leg elevation for ankle oedema",
            "timing": "Start Now",
            "reasons": [
              "Symptomatic relief of puffy ankles while systemic causes are investigated",
              "Conservative management appropriate in a haemodynamically stable patient without cardiorespiratory compromise",
              "May reduce discomfort and improve mobility"
            ]
          },
          {
            "treatment": "Optimisation of glycaemic control with diet, lifestyle, and pharmacologic therapy if diabetes or pre-diabetes is confirmed",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of abnormal glucose metabolism with HbA1c and fasting glucose",
              "Choice of agents should be individualised based on comorbidities and renal/hepatic function",
              "Tight glycaemic control slows progression of diabetic neuropathy but should be planned with primary care or endocrinology"
            ]
          },
          {
            "treatment": "Vitamin B12 replacement therapy if deficiency is identified",
            "timing": "Delay",
            "reasons": [
              "B12 status must be confirmed to avoid masking other diagnoses and unnecessary treatment",
              "Dosing and route (oral vs intramuscular) depend on severity and cause of deficiency",
              "Correcting deficiency can halt or partially reverse neuropathic deficits"
            ]
          },
          {
            "treatment": "Disease-specific immunotherapy for chronic inflammatory demyelinating polyradiculoneuropathy (e.g., corticosteroids, intravenous immunoglobulin, or plasma exchange) if confirmed",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of demyelinating neuropathy on nerve conduction studies and supportive clinical/laboratory criteria",
              "Immunotherapies have significant risks and costs and should not be given empirically in mild, slowly progressive neuropathy",
              "Should be initiated in consultation with a neuromuscular specialist"
            ]
          },
          {
            "treatment": "Neuropathic pain medication (e.g., amitriptyline, duloxetine, gabapentin, or pregabalin) if the patient reports troublesome neuropathic pain",
            "timing": "Delay",
            "reasons": [
              "No pain symptoms are currently documented; treatment should be tailored to symptom burden",
              "Choice of agent depends on comorbidities, potential drug interactions, and patient preference",
              "Initiation can follow once full assessment clarifies aetiology and contraindications"
            ]
          },
          {
            "treatment": "Avoidance or minimisation of neurotoxic medications and toxins",
            "timing": "Start Now",
            "reasons": [
              "Many drugs and toxins (e.g., certain chemotherapeutics, excessive vitamin B6, heavy alcohol use) can worsen neuropathy",
              "Medication review can be completed immediately and harmful agents reduced or stopped",
              "Prevents further axonal injury while diagnostic workup is ongoing"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Disease-specific immunotherapy for chronic inflammatory demyelinating polyradiculoneuropathy (e.g., corticosteroids, intravenous immunoglobulin, or plasma exchange) if confirmed",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of demyelinating neuropathy on nerve conduction studies and supportive clinical/laboratory criteria",
              "Immunotherapies have significant risks and costs and should not be given empirically in mild, slowly progressive neuropathy",
              "Should be initiated in consultation with a neuromuscular specialist"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [],
              "contraindications": [
                "Presenting complaint is not necessarily a symptom of MS so indication for steroids is unclear."
              ]
            }
          },
          "evaluation_summary": "Not appropriate to suggest treatment at this time.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not necessarily a symptom of MS so indication for steroids is unclear."
        },
        "dmt_evaluation": {
          "ft_plan": null,
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Inappropriate omission. The plan failed to consider this possible treatment option.\n  \nAdditional factors not mentioned:\n\n- Need confirmation of MS diagnosis.\n\n- Need a pregnancy test result."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 1,
          "reasons_acknowledged": 0,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "inappropriate_omission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 0,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.0
        }
      }
    }
  }
}